Published in Ann Clin Biochem on January 01, 1976
Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg (1978) 1.46
Progress report. Cancer of the pancreas. Gut (1977) 1.36
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
Mapping epitope characteristics on carcinoembryonic antigen. Br J Cancer (1986) 1.18
Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line. Br J Cancer (1977) 1.02
The value of tumour markers in lung cancer. Br J Cancer (1988) 0.93
Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2. J Clin Pathol (1990) 0.90
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
C1q binding activity in the sera of patients with chronic lung diseases. Clin Exp Immunol (1981) 0.84
Cancer-associated proteins in effusion fluids. J Clin Pathol (1977) 0.83
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease. J Clin Pathol (1984) 0.82
Serum levels of human placental lactogen and pregnancy-specific beta 1-glycoprotein in breast cancer. Br J Cancer (1982) 0.82
Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours. Arch Dis Child (1978) 0.81
Clinicopathological role of tumour index substances in paediatric neoplasia. J Clin Pathol (1976) 0.77
Tumour-associated antigens: still too fickle for population screening. Br Med J (1977) 0.75
Biochemical profiles in tumour monitoring and their analysis. Proc R Soc Med (1977) 0.75
The diagnostic value of plasma carcinoembryonic antigen (CEA) in pancreatic disease. Medical Research Council Tumour Products Committee: Clinical Subgroup. Br J Cancer (1980) 0.75
Products of gynaecological neoplasms: clinical and pathological applications. Arch Gynecol (1980) 0.75
Carcinoembryonic antigen in endoscopic brush specimens from benign and malignant gastric lesions. Br J Cancer (1979) 0.75
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J (1972) 5.48
A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol (1977) 3.77
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet (1999) 3.50
Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer (1972) 2.53
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17
Clinical and economic benefits of ramipril: an Australian analysis of the HOPE study. Intern Med J (2003) 2.16
Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res (1982) 2.07
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet (1976) 1.92
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88
Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A (2001) 1.87
Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Br J Cancer (1973) 1.83
The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer (1973) 1.81
Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J (1974) 1.69
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol (1982) 1.68
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Are breast cancer axillary node micrometastases worth detecting? J Pathol (1990) 1.57
Renal proximal dysfunction in patients with rheumatic diseases. Br Med J (Clin Res Ed) (1984) 1.57
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. Br J Urol (1988) 1.55
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Sodium dodecyl sulphate polyacrylamide gel electrophoresis patterns of proteinuria in various renal diseases of childhood. Pediatr Nephrol (1991) 1.47
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol (1981) 1.46
Quantitation of the response of lymphocytes in culture to specific and non-specific stimulation. Int Arch Allergy Appl Immunol (1967) 1.44
[Degradation of thymidine by transformed lymphocytes]. Rev Fr Etud Clin Biol (1965) 1.43
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
Analyses of DNA content, nuclear size and cell proliferation of transitional cell carcinoma in man. Cancer (1969) 1.41
Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder. Cancer (1971) 1.41
Potential pathological application of immunocytochemical methods to the detection of micrometastases. Cancer Res (1980) 1.41
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
Immunologically stimulated human peripheral blood lymphocytes in vitro. I. Morphological changes. Int Arch Allergy Appl Immunol (1966) 1.37
Intrathoracic phaeochromocytoma. Br J Surg (1970) 1.36
Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCEA-2. Preparation and chemical characterisation. Immunochemistry (1973) 1.34
C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol (1984) 1.34
Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer (1980) 1.31
Morphological responses to corticotrophin and cyclic AMP by adult rat adrenocortical cells in monolayer culture. J Endocrinol (1973) 1.31
Cancer of the urinary tract. Adv Cancer Res (1970) 1.28
Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27
Evaluation of a radioimmunoassay for neuron specific enolase in small cell lung cancer. Br J Cancer (1985) 1.25
Cell proliferation in Burkitt tumours. Eur J Cancer (1966) 1.25
Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol (1983) 1.25
Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies. Br J Cancer (1981) 1.24
Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer (1977) 1.24
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg (1985) 1.23
The pathology of the adrenal gland in Cushing's syndrome. J Pathol Bacteriol (1967) 1.23
Cell death in normal and malignant tissues. Adv Cancer Res (1975) 1.22
Serum beta 2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol (1984) 1.22
CEA, ZGM and EMA localization in cells of pleural and peritoneal effusion: a preliminary study. Invest Cell Pathol (1981) 1.22
Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg (1984) 1.20
The prognostic influence of serum neuron specific enolase in small cell lung cancer. Br J Cancer (1988) 1.18
Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med (1983) 1.17
Tubular dysfunction and microalbuminuria in insulin dependent diabetes. Arch Dis Child (1988) 1.16
Immunoreactive calcitonin production by human lung carcinoma cells in culture. Br J Cancer (1975) 1.16
N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis. J Natl Cancer Inst (1981) 1.16
The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. Br J Cancer (1993) 1.15
Results of the MRC myelomatosis trials for patients entered since 1980. Hematol Oncol (1988) 1.15
The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis. Br J Cancer (1985) 1.15
Monoclonal antibodies to detect human tumours: an experimental approach. J Clin Pathol (1981) 1.15
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14
CEA and tumor markers. Semin Oncol (1976) 1.13
Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (1983) 1.12
Acute phase reactant proteins in cancer. Adv Cancer Res (1979) 1.12
Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin. Am Heart J (1971) 1.11
Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer. Eur J Cancer Clin Oncol (1989) 1.10
The clinical and pathologic features of "non-hormonal" adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer (1974) 1.08
Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring. Br J Cancer (1980) 1.08
Human breast tumour-induced osteolysis and prostaglandins. Prostaglandins (1976) 1.07
Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial. J Clin Pathol (1984) 1.07
Monolayer culture of normal adult and neoplastic cells of the rat and human adrenal cortex. Proc R Soc Med (1974) 1.06
Pathology of primary aldosteronism. Cancer (1966) 1.06
Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen. Br J Cancer (1981) 1.05
Report of the workshop on the carcinoembryonic antigen (cea): the present position and proposals for future investigation. Int J Cancer (1974) 1.04
Proliferative activity of leukaemic cells at various stages of acute leukaemia of childhood. Br J Haematol (1968) 1.04
Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer (1984) 1.04
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer (1980) 1.03
The biology of cell death in tumours. Cell Tissue Kinet (1973) 1.03
Carcinoembryonic antigen and urothelial carcinoma. Br J Urol (1973) 1.03
The thoracic duct lymph in Hodgkin's disease. II. Quantitative analysis of the cellular composition of the lymph. Int J Cancer (1971) 1.02
Lymphocyte infiltration in bladder carcinoma. Rev Eur Etud Clin Biol (1970) 1.01
Alpha-globulins in the surveillance of colorectal cancer. Biomedicine (1976) 1.01
The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol (1988) 1.01
Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia. Biosci Rep (1981) 1.01
Isolation and characterization of a major glycoprotein from milk-fat-globule membrane of human breast milk. Biochem J (1981) 1.00
Preparation and identification of human breast epithelial cells in culture. Int J Cancer (1980) 1.00
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer (1968) 1.00
Letter: Syncytiotrophoblasts in malignant testicular tumours. Lancet (1976) 0.99
Biochemical markers in bronchogenic carcinoma. Br J Dis Chest (1978) 0.99
Chromosome constitution of transitional cell carcinoma of the urinary bladder. Cancer (1972) 0.99
Monoclonal antibodies to the human mammary gland. II. Distribution of determinants in breast carcinomas. Virchows Arch A Pathol Anat Histol (1982) 0.99
Serum beta 2-microglobulin and human immunodeficiency virus infection. AIDS (1987) 0.99
A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98
Polycyclic hydrocarbon activation and metabolism in epithelial cell aggregates prepared from human mammary tissue. Int J Cancer (1980) 0.97
DNA synthesis and DNA content of leucocytes in acute leukaemia. Nature (1967) 0.97
Blood muramidase activity in colorectal cancer. Br Med J (1974) 0.97